Bening prostatic hyperplasia (BPH) is a histopathological diagnosis characterized by proliferation of smooth muscle and epithelial cells in the transitional zone of the prostate. Lasers are mainly used in the treatment of BPH with three principles: vaporization, resection and enucleation. The European Society of Urology recommends laser enucleation as an alternative to transurethral resection (TUR-P) or open prostatectomy in recent guidelines. Various studies have shown that laser therapy is equivalent to transurethral resection and open prostatectomy in reducing hemoglobin, complications, hospitilization and revision rate, symptom relief and improving quality of life. Although it has been stated that even large prostate tissues can be treated minimally invasively with the transurethral approach with laser methods, which is an alternative method, it reduces morbidity, shortens hospitalization and catheterization times, reduces blood loss and the need for blood transfusion, but due to the limited long-term case follow-up series, TUR-P is not recommended. It can be predicted that it has not taken its place yet, but that it is a strong candidate for it.